Pharmacogenomics. 2010 Feb;11(2):135-9.

Pharmacogenetics of hepatitis C therapy.

Source

Weill Medical College of Cornell University, Division of Gastroenterology and Hepatology, New York Presbyterian Hospital, 1305 York Avenue, 4th Floor, New York, NY, USA.

Comment on

PMID:: 20136353; [PubMed]

Free full text

Publication Types

Comment

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Review Hepatitis C virus infection: early diagnosis and identification of response to antiviral therapy. [Expert Rev Mol Diagn. 2001]
Review Hepatitis C virus infection: early diagnosis and identification of response to antiviral therapy.
Bonino F, Colombatto P, Civitano L, Coco B, Oliveri F, Brunetto MR. Expert Rev Mol Diagn. 2001 Sep; 1(3):310-4.
Gene-gene and gene-environment interactions in interferon therapy for chronic hepatitis C. [Pharmacogenomics. 2007]
Gene-gene and gene-environment interactions in interferon therapy for chronic hepatitis C.
Lin E, Hwang Y, Chen EY. Pharmacogenomics. 2007 Oct; 8(10):1327-35.
Review Viral factors affecting the outcome of therapy for chronic hepatitis C. [Rev Gastroenterol Disord. 2004]
Review Viral factors affecting the outcome of therapy for chronic hepatitis C.
Fried MW. Rev Gastroenterol Disord. 2004; 4 Suppl 1:S8-S13.
Pharmacogenomics of hepatitis C and decision analysis: a glimpse into the future. [Hepatology. 2002]
Pharmacogenomics of hepatitis C and decision analysis: a glimpse into the future.
Wong JB. Hepatology. 2002 Jul; 36(1):252-4.
Characteristic sequence changes of hepatitis C virus genotype 2b associated with sustained biochemical response to IFN therapy. [J Viral Hepat. 2005]
Characteristic sequence changes of hepatitis C virus genotype 2b associated with sustained biochemical response to IFN therapy.
Tanabe Y, Nagayama K, Enomoto N, Izumi N, Tazawa J, Kurosaki M, Sakamoto N, Sato C, Watanabe M. J Viral Hepat. 2005 May; 12(3):251-61.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Pharmacogenetics of hepatitis C therapy.
Pharmacogenetics of hepatitis C therapy.
Pharmacogenomics. 2010 Feb ;11(2):135-9.

PubMed
Plasma histamine in patients with chronic renal failure and nephrotic syndrome.
Plasma histamine in patients with chronic renal failure and nephrotic syndrome.
J Clin Pathol. 1991 Mar ;44(3):243-5.

PubMed
Reconstruction and analysis of human liver-specific metabolic network based on C...
Reconstruction and analysis of human liver-specific metabolic network based on CNHLPP data.
J Proteome Res. 2010 Apr 5 ;9(4):1648-58.

PubMed
Volar dislocation of the distal radio-ulnar joint. A case report.
Volar dislocation of the distal radio-ulnar joint. A case report.
J Bone Joint Surg Am. 1991 Apr ;73(4):617-9.

PubMed
[Anatomical double bundle reconstruction of medial patellofemoral ligament with ...
[Anatomical double bundle reconstruction of medial patellofemoral ligament with allograft tendon in patellar dislocations].
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2010 Jan ;24(1):100-3.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Pharmacogenetics of hepatitis C therapy.

Source

Comment on

Publication Types

Publication Types

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information